Guo H, Ding Q, Gong Y, Gilcrease MZ, et al. Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res 2020;22:69.
PMID: 32576238